Checked.be
Active
BE 0418.203.325Public limited company
MECONDOR
Mercatorstraße 7 ·4780 Sankt Vith, Belgium· 48 yrs active
Sector: Manufacture of chemicals and chemical products
(20600)
Conclusion
MECONDOR has been active since 1978 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €9.23M and a net result of €352k. Equity is growing by ~4.7% per year across the filed fiscal years. Its solvency ranks better than 93% of 259 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Based on the State Gazette, CBE and 4 annual accounts.
Key figures
| Equity | €9.23M |
| Net result | €352k |
| Staff (FTE) | 37 |
| Better than sector | 93% |
Financial profile
72
/ 100
Strong profile, led by solvency.
All 5 axes are computed from data Checked has read.
Health
88
Profitability
36
Solvency
100
Growth
37
Stability
100
Bankruptcy probability (12 mo)
Risk Assessment
0 / 100
Low riskTrust signals
Long-established
Founded in 1978, 48 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Checked score
88
/ 100
Excellent
Computed from 6 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Indicative credit limit
€800k
estimate, not credit advice
Score history
88
2022
88
2023
100
2024
88
2025
purely financial, excl. current insolvency signals
Score components
Liquidity
Current ratio 5.01 (≥ 1.5)
+10
Quick ratio
Quick ratio 3.85 (≥ 1.0)
+5
Leverage
Debt/equity 0.13 (< 1.0)
+10
Profitability
ROE 4%
+3
EBITDA margin
EBITDA-marge 9%
+2
Interest coverage
Interest coverage 53921.0× (≥ 3×)
+8
Profit trend
Net profit down YoY
-3
Equity growth
Equity growing YoY
+3
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.
Financial overview
Annual accounts filed on 12-08-2026 with the NBB · fiscal year 2025 · full schema
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing
Equity: growth of ~4.7%/year over 4 fiscal years, indicative, assuming unchanged policy.
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Sector comparison
Fiscal year 2025 · NACE 20, Manufacture of chemicals and chemical products · compared within the same schema type (full schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 88.6% | 50.4% | |
| Net result | €352k | €434k | |
| Equity | €9.23M | €8.57M | |
| Staff costs | €2.16M | €4.03M | |
| Employees (FTE) | 37.0 | 43.7 |
€10.65M
-12.5%
22-25
€981k
-42.5%
22-25
€352k
-67.7%
22-25
€754k
-48.7%
22-25
€10.42M
+2.1%
22-25
€9.23M
+0.9%
22-25
€4.75M
-15.1%
22-25
37
0.0%
22-25
€2.16M
-8.7%
22-25
€125k
-66.3%
22-25
€244k
0.0%
22-25
€1.18M
+12.0%
22-25
€1.18M
+12.0%
22-25
5.01
-20.4%
22-25
3.85
-17.7%
22-25
88.6%
-1.1%
22-25
0.13
+11.0%
22-25
3.8%
-68.0%
22-25
3.4%
-68.3%
22-25
3.3%
-63.0%
22-25
9.2%
-34.2%
22-25
53921.01
+16011.4%
22-25
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Deposit | full schema | full schema | full schema | full schema |
| Revenue | €10.65M | €12.17M | €12.12M | €13.61M |
| EBITDA | €981k | €1.71M | €896k | €1.12M |
| Net profit | €352k | €1.09M | €283k | €684k |
| Cash flow | €754k | €1.47M | €688k | €1.11M |
| Staff costs | €2.16M | €2.37M | €2.42M | €2.43M |
| Income taxes | €125k | €371k | €104k | €232k |
| Dividends | €244k | €244k | €244k | €600k |
| Total assets | €10.42M | €10.21M | €9.99M | €10.30M |
| Equity | €9.23M | €9.14M | €8.32M | €8.19M |
| Debt | €1.18M | €1.06M | €1.66M | €2.11M |
| of which ≤ 1y | €1.18M | €1.06M | €1.66M | €2.11M |
| of which > 1y | - | - | - | - |
| Working capital | €4.75M | €5.59M | €4.96M | €4.63M |
| Employees (FTE) | 37.0 | 37.0 | 40.6 | 49.0 |
Ratios (computed)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Current ratio | 5.01 | 6.29 | 3.98 | 3.19 |
| Quick ratio | 3.85 | 4.68 | 3.06 | 2.33 |
| Working capital ratio | 45.6% | 54.8% | 49.7% | 44.9% |
| Solvency | 88.6% | 89.6% | 83.3% | 79.5% |
| Debt / equity | 0.13 | 0.12 | 0.20 | 0.26 |
| Long-term debt ratio | - | - | - | - |
| Interest coverage | 53921.01 | 334.68 | 69009.79 | 891.71 |
| Gross margin | 44.0% | 41.5% | 37.1% | 35.7% |
| Net margin | 3.3% | 9.0% | 2.3% | 5.0% |
| ROA | 3.4% | 10.7% | 2.8% | 6.6% |
| ROE | 3.8% | 11.9% | 3.4% | 8.4% |
| EBITDA margin | 9.2% | 14.0% | 7.4% | 8.2% |
| Days sales outstanding | 88d | 69d | 84d | 92d |
| Days payable outstanding | 36d | 25d | 54d | 36d |
| Inventory turnover | 4.33 | 4.17 | 4.97 | 4.83 |
| Days inventory (DSI) | 84d | 88d | 73d | 76d |
Balance-sheet composition 2025
Full annual accounts (26 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Balance sheet, Assets | |||||
| TOTAL ASSETS | 20/58 | €10.42M | €10.21M | €9.99M | €10.30M |
| Fixed assets | 21/28 | €4.49M | €3.56M | €3.37M | €3.57M |
| Tangible fixed assets | 22/27 | €3.87M | €2.94M | €2.75M | €2.95M |
| Financial fixed assets | 28 | €621k | €621k | €620k | €620k |
| Current assets | 29/58 | €5.93M | €6.64M | €6.63M | €6.74M |
| Stocks & contracts in progress | 3 | €1.38M | €1.71M | €1.53M | €1.81M |
| Amounts receivable within one year | 40/41 | €2.67M | €2.40M | €2.91M | €4.42M |
| Investments | 50/53 | €881k | €1.50M | €1.73M | - |
| Cash & bank | 54/58 | €955k | €998k | €413k | €465k |
| Balance sheet, Equity & liabilities | |||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €10.42M | €10.21M | €9.99M | €10.30M |
| Equity | 10/15 | €9.23M | €9.14M | €8.32M | €8.19M |
| Contributions / capital | 10/11 | €348k | €348k | €348k | €348k |
| Reserves | 13 | €326k | €326k | €326k | €326k |
| Accumulated profits (losses) | 14 | €8.41M | €8.30M | €7.45M | €7.41M |
| Provisions & deferred taxes | 16 | €5k | €5k | €5k | €5k |
| Amounts payable | 17/49 | €1.18M | €1.06M | €1.66M | €2.11M |
| Amounts payable within one year | 42/48 | €1.18M | €1.06M | €1.66M | €2.11M |
| Trade debts payable within one year | 44 | €587k | €495k | €1.13M | €852k |
| Income statement | |||||
| Turnover | 70 | €10.65M | €12.17M | €12.12M | €13.61M |
| Operating result | 9901 | €580k | €1.33M | €491k | €693k |
| Financial income | 75 | €77k | €139k | €46k | €230k |
| Financial charges | 65 | €180k | €5k | €151k | €7k |
| Result before taxes | 9903 | €478k | €1.46M | €387k | €916k |
| Income taxes | 67/77 | €125k | €371k | €104k | €232k |
| Net result for the period | 9904 | €352k | €1.09M | €283k | €684k |
| Result to be appropriated | 9905 | €352k | €1.09M | €283k | €684k |
Legal Structure
| NACE primary | Manufacture of chemicals and chemical products(20600) |
| Legal form | Public limited company(014) |
| Incorporation | 21-04-1978 |
| Status | Active |
| Postal code | 4780 |
Establishment units
Rodter Strasse 26, 4780 Sankt Vith
since 19782.014.891.324
Prümer Strasse 19, 4780 Sankt Vith
since 19782.332.939.773
Mercatorstraße 7, 4780 Sankt Vith
since 20212.332.939.872
Updates
Next filing, fiscal year 2026, expected by
2026
12-08
NBB filing
Annual accounts filed
fiscal year 2025 · full schema · 12 days late
2025
12-08
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 12 days late
2024
31-12
Financial
Highest result since 2022net €1.09M ▲285%
Operating result €1.33M, net result €1.09M, both a record.
20-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 20 days late
2023
31-12
Financial
Weakest financial yearnet €283k ▼58.6%
Net result drops to €283k, the lowest in the series; recovery starts the following year.
22-08
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 22 days late
2022
11-08
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 11 days late
2021
23-08
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 23 days late
2020
28-08
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 28 days late
2019
27-08
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 27 days late
2018
27-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 27 days late
2017
30-08
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Belgian State Gazette reading coverage
We know of 6 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Credit advice
Company registry (CBE)
Activities
Manufacture of chemicals and chemical products20600Manufacture of rubber and plastic products2226025240
Names & trade names
| Legal nameFR | MECONDOR |
Similar companies
INTASA
BE 0405.047.650 · Schilde
PLASCOBEL
BE 0808.587.941 · Pelt
DS Fiberlink
BE 0425.100.817 · Dendermonde
Adfil
BE 0726.870.587 · Zele
LUXILON INDUSTRIES
BE 0443.802.417 · Wijnegem